Previously, Sanger sequencing of amplified exons 5–8 of TP53 revealed missense mutations in 20% of canine STS samples, with 3 of 7 variants identified in PNST samples and no variants were identified among 3 fibrosarcomas tested8. The gene discussed is TP53; the disease is fibrosarcoma.